Date | Title | Description | Source |
20.03.2024 | Startup Lands $150M for Delicate Dance Between Cancer Cells ... | Cancer immunotherapy comes in several forms, and one area of growing research interest is a type of ... | medcitynew... |
16.06.2022 | Tech layoffs at private companies are putting employee equit... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
15.06.2022 | 'Third Rock forever': Firm's latest $1.1B funding round will... | Third Rock Ventures just closed out a massive $1.1 billion fund, bringing its total raised over the ... | fiercebiot... |
06.06.2019 | Third Rock Ventures Closes Fund V, at $770M | Third Rock Ventures, LLC, a Boston, MA-based life sciences venture capital firm, closed Third Rock V... | finsmes.co... |
06.06.2019 | Top tech startup news for today, Thursday, June 6, 2019 | Good morning! Below are some of the top tech startup news for today, Thursday, June 6, 2019.
Apple ... | techstartu... |
09.08.2018 | Top tech startup news stories you need to know this Thursday... | Good morning! Here are some of the top tech startup news stories for today, Thursday, August 9.
Rev... | techstartu... |
05.05.2018 | AI researcher from Alphabet’s Calico Labs launches startup a... | To enable the machine learning, we will use high-quality data that has already been collected, but w... | medcitynew... |
03.05.2018 | Third Rock Ventures Launches Casma Therapeutics with $58.5 M... | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Casma Therapeutics, Inc., a biotechnology company harnessing the ... | archive.ci... |
24.04.2018 | Third Rock Invests $56.2M in Series A Funding for Cedilla Th... | Cedilla Therapeutics, a new biotechnology company broadening the reach of small molecule therapeutic... | archive.ci... |
24.04.2018 | Third Rock Invests $56.2M in Series A Funding for Cedilla Th... | Cedilla Therapeutics, a new biotechnology company broadening the reach of small molecule therapeutic... | citybizlis... |
22.03.2018 | Rheos Medicines Raises $60M in Series A Funding | Rheos Medicines, Inc., a Cambridge, Mass.-based is a biopharmaceutical company developing novel medi... | finsmes.co... |
28.07.2017 | A race is underway to repair our hearing — with medicine | On any bustling city street, in the middle of the afternoon, it’s probably the case that half or mor... | techcrunch... |
20.06.2017 | venture leaders Life Science 2017: Walk the investors’ talk... | venture leaders Life Science 2017: Walk the investors’ talk 20.06.2017 10:00, Lara Rossi linkedIn fa... | venturelab... |
20.06.2017 | venture leaders Life Science 2017: Walk the investors’ talk... | Monday: Rolling the pitch
PAREXEL, 7:30AM. A short night after landing at Logan airport, the partici... | venturekic... |
31.03.2017 | Tango Therapeutics Raises $55m in Series A Funding | Tango Therapeutics, a Cambridge, MA-based new cancer therapeutics company, raised $55m in Series A f... | finsmes.co... |
26.01.2017 | Third Rock Ventures Adds Sarah Larson as Partner & Chief... | Healthcare venture capital firm Third Rock Ventures has added Sarah Larson as partner and chief huma... | finsmes.co... |
26.01.2017 | Third Rock Ventures Names Sarah Larson as Partner | BOSTON--(BUSINESS WIRE)--Third Rock Ventures, LLC today announced that Sarah Larson has joined as pa... | citybizlis... |
09.01.2017 | Two biotech startups tackle hearing loss | “It’s noise pollution,” said David Lucchino, president and CEO at Frequency, said in a phone intervi... | medcitynew... |
16.11.2016 | Stem cell startup Magenta launches with $48.5m | In a company news release, Jason Gardner, CEO, president, and co-founder of Magenta Therapeutics sai... | medcitynew... |
03.11.2016 | Third Rock Ventures Closes Fund IV at $616M | Third Rock Ventures, LLC, a Boston, MA-based healthcare venture capital firm, closed fund IV, at $61... | finsmes.co... |
31.10.2016 | Third Rock Ventures closes $616 million healthcare fund | Fund IV has not yet begun investing, according to a company representative, but the firm has establi... | medcitynew... |
31.10.2016 | Term Sheet — Monday, October 31 | Another Day, Another Megamerger
At this pace the Fortune 500 will be down to around 20 companies by ... | fortune.co... |
24.10.2016 | Here’s what it would take for GV (Google Ventures) to invest... | That abiding philosophy hasn’t yet found anything interesting in the consumer wearable arena to cons... | medcitynew... |
16.09.2016 | Protein-motion startup launches armed with $57M to develop d... | Molecular-level movies may not spark the imagination of too many directors. But for oncology patient... | medcitynew... |
26.03.2016 | What life science investors got right in this most recent bo... | It’s long been the case that life sciences investors don’t get the attention that their more traditi... | techcrunch... |
18.02.2016 | Pliant Therapeutics Raises $45M in Series A Financing | Pliant Therapeutics, Inc., a newly formed Redwood City, California-based company that aims to discov... | finsmes.co... |
07.01.2016 | Healthcare Venture Capital Firm Third Rock Ventures Adds Mic... | Boston, MA-based healthcare venture capital firm Third Rock Ventures, LLC, has added Michael W. Bonn... | finsmes.co... |
15.10.2015 | Daily funding roundup - October 15, 2015 | Quip secured $30M; OpenGov raised $25M; Niantic landed $20M
OpenGov, which allows local governments ... | vator.tv/n... |
15.10.2015 | Decibel Therapeutics Launches with $52M Series A Financing | Decibel Therapeutics, a Cambridge, Mass.-based newly formed hearing company focused on discovering a... | finsmes.co... |
15.10.2015 | Third Rock hearing loss startup Decibel Therapeutics launche... | Indeed, Third Rock companies generally take this broad scale approach to their respective fields – t... | medcitynew... |
01.10.2015 | Daily funding roundup - October 1, 2015 | General Assembly raised $70M; Neon Therapeutics secured $55M; Dolly landed $8M
Social Finance (SoFi ... | vator.tv/n... |
10.08.2015 | Genome editing company Editas gets infused with $120M | Investors in the company include Google Ventures, Khosla Ventures and Bill Gates
We like to complain... | vator.tv/n... |
04.02.2015 | REVOLUTION Medicines Launches with $45M Series A |
REDWOOD CITY, CA, Third Rock Ventures today announced the formation of REVOLUTION Medicines, Inc. ... | vcnewsdail... |
04.02.2015 | Like a Lego: Third Rock’s $45M venture makes synthesizing na... | The technology comes from chemist Martin Burke at the University of Illinois, who has formulated jus... | medcitynew... |
04.02.2015 | Revolution Medicines Raises $45M Series A Financing | Revolution Medicines, Inc., a Redwood City, CA-based newly formed developer of new therapies derived... | finsmes.co... |
06.08.2014 | Epigenetics player Constellation Pharma raises $5 million; l... | Constellation Pharmaceuticals also announced it has begun two additional Phase 1 clinical studies of... | medcitynew... |
22.05.2014 | Nurix Raises $25.1M in Series B Financing | Nurix, Inc., a San Francisco, California-based company that discovers and develops therapies that mo... | finsmes.co... |
15.04.2014 | PanOptica Closes Up To $45M in Series B Funding | PanOptica, a Bernardsville, NJ-based biopharmaceutical company focused on ophthalmology therapies, c... | finsmes.co... |
12.02.2014 | Voyager Therapeutics Launches with $45M in Series A Financin... | Voyager Therapeutics, a Cambridge, Mass.-based newly formed gene therapy company developing life-cha... | finsmes.co... |
20.01.2014 | The 4 Winners of the Blue Button Innovation Challenge Changi... | In three days, 15 startups emerged, aimed at changing an industry that daily impacts every single in... | bizjournal... |
08.01.2014 | Blueprint Medicines Completes $25M Series B Financing | Blueprint Medicines, a Cambridge, MA-based oncology company, completed a $25m Series B financing.
Th... | finsmes.co... |
25.11.2013 | Editas Medicine Secures $43M Series A Financing | Editas Medicine, a Cambridge, MA-based genome editing company, secured a $43m Series A financing.
Th... | finsmes.co... |
02.08.2013 | Edimer Secures $18M Series B Financing Led by New Enterprise... | | startuptic... |
27.03.2013 | Venture capital: Third Rock Ventures’ new $516M fund, invest... | Third Rock Ventures, one of the premiere healthcare venture capital firms, is loaded for bear again.... | massdevice... |
25.03.2013 | Third Rock Ventures Close Third Fund at $516M | Third Rock Ventures, LLC, a Boston, MA-based venture capital firm focused on backing healthcare comp... | finsmes.co... |
25.03.2013 | Third Rock Ventures gets its hands dirty with $516M for heal... | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI an... | venturebea... |
25.03.2013 | No shying away from early-stage deals here. Third Rock Ventu... | Since its inception in 2007, the firm has raised about $1.3 billion and funded or launched 31 compan... | medcitynew... |
25.03.2013 | Third Rock Ventures gets its hands dirty with $516M for heal... | With surgery, it’s important to take a hands-on approach. The same applies to investing. Third Rock ... | venturebea... |
14.02.2013 | New biotech startup for therapeutic cancer vaccines includes... | The funding will help build Jounce’s product engine to develop biologics with a broad spectrum of ta... | medcitynew... |
14.02.2013 | Jounce Therapeutics Raises $47M in Series A Financing from T... | Jounce Therapeutics, Inc., a Cambridge, MA-based newly formed company focused on the discovery and d... | finsmes.co... |
17.10.2012 | Cibiem Raises $10M in Series A Financing | Cibiem, a New York City-based medical device startup, has raised $10m in Series A financing.
Backers... | finsmes.co... |
20.09.2012 | MyoKardia Raises $38M in Series A Financing | MyoKardia, Inc., a San Francisco, CA-based newly formed company that is developing a pipeline of nov... | finsmes.co... |
27.07.2012 | Fundraising: Gene therapy firm targeting sickle cell anemia ... | Product: Gene therapy to target sickle cell anemia, beta-thalassemia and childhood cerebral adrenole... | medcitynew... |
14.06.2012 | Global Blood Therapeutics Raises $40.7M in Series A Financin... | Global Blood Therapeutics, Inc., a San Francisco, CA-based newly formed product-focused company buil... | finsmes.co... |
14.06.2012 | Venture firm launches rare blood disorder therapeutics devel... | Among the company’s founders are three scientific researchers from University of California, San Fra... | medcitynew... |
24.05.2012 | Blueprint Medicines Adds Fidelity Biosciences | Blueprint Medicines, a Cambridge, MA-based developer of personalized cancer therapies, announced Fid... | finsmes.co... |
21.03.2012 | GSK, JNJ form $200M fund with Index Ventures for early stage... | But the investments and the board seats don’t necessarily mean the fund stands ready to fill GSK and... | medcitynew... |
24.02.2012 | Sanofi’s Viehbacher thinks Big Pharma will seek earlier-stag... | But just as important, the agreement provides an exit for Warp Drive’s investors. The partnership is... | medcitynew... |
31.01.2012 | FDA-approved cancer drug gets revised label, better results ... | The cancer drug made the cover of Time magazine in 2001 around the time it was first approved by the... | medcitynew... |
11.01.2012 | Warp Drive Bio Raises $125M | Warp Drive Bio, a Boston, MA-based newly formed company that is developing proprietary genomic searc... | finsmes.co... |
15.12.2011 | Ember Therapeutics Launches with $34M in Series A Financing ... | Ember Therapeutics, a Boston, MA-based newly formed company focused on leveraging recent findings in... | finsmes.co... |
17.11.2011 | Agios Pharmaceuticals Raises $78M in Series C Financing | Agios Pharmaceuticals, a Cambridge, Massachusetts-based biopharmaceutical company focused on discove... | finsmes.co... |
16.11.2011 | Allena Pharmaceuticals Raises $15M in Series A Venture Capit... | Allena Pharmaceuticals, Inc., a Newton, Mass.-based company developing and commercializing innovativ... | finsmes.co... |
18.10.2011 | TOPICA Pharmaceuticals Raises $27M in Series B Funding | TOPICA Pharmaceuticals, Inc., a Palo Alto, CA-based clinical research stage pharmaceutical company, ... | finsmes.co... |
18.10.2011 | Foundation Medicine Closes $33.5M Expanded Series A Financin... | Foundation Medicine, Inc., a Cambridge, MA-based cancer diagnostics company that aims to bring compr... | finsmes.co... |
18.10.2011 | SAGE Therapeutics Raises $35M in Series A Funding from Third... | SAGE Therapeutics, a Boston, MA-based newly formed company that focuses on building central nervous ... | finsmes.co... |
22.09.2011 | Sabet and Wilson Out at Twitter, Hirshland Out at Polaris, &... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Catching up on an eventful week in ... | xconomy.co... |
30.06.2011 | Lotus Tissue Repair Closes $26M Series A Financing | Lotus Tissue Repair, a Cambridge, MA-based developer of recombinant collagen type VII (rC7) technolo... | finsmes.co... |
15.09.2010 | Third Rock raises $426 million, opens in San Fran | Boston investment firm Third Rock Ventures LLC has raised $426 million for its second (oversubscribe... | massdevice... |
14.09.2010 | Third Rock Ventures raises $426M, opens West Coast office | Founded in 2007 with a $378 million fund, Third Rock has invested in 15 life sciences companies, inc... | medcitynew... |
13.09.2010 | Third Rock Ventures Closes $426M Venture Capital Fund | Third Rock Ventures, L.L.C, a Boston, MA-based venture capital firm focused on building life science... | finsmes.co... |
17.04.2010 | Foundation Medicine Completes $25M Series A Financing | Foundation Medicine, Inc., a Boston, MA-based personalized cancer medicine company that aims to brin... | finsmes.co... |
29.04.2008 | Constellation Off to a Stellar $32 Million Start, Helmed (Fo... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Constellation Pharmaceuticals, a ne... | xconomy.co... |
14.12.2007 | Third Rock Hires Three Partners—Says Team Complete to Implem... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Third Rock Ventures, the new Boston... | xconomy.co... |
14.09.2007 | Life sciences briefing: Friday, Sept. 14, 2007 | Featured companies: Accenx, Chlorogen, Third Rock Ventures
Ex-Millennium execs found new life-scienc... | venturebea... |
- | Here’s what it would take for GV (Google Ventures) to invest... | Krishna Yeshwant, general partner, GV
Perusing the life sciences and health portfolio of GV (formerl... | medcitynew... |
- | Stem cell startup Magenta launches with $48.5m | Two top-tier biotech venture firms have collaborated for the first time to create, incubate, and lea... | medcitynew... |
- | Third Rock Ventures closes $616 million healthcare fund | Third Rock Ventures announced Monday that it had closed its fourth fund — it’s largest, Third Rock V... | medcitynew... |
- | Like a Lego: Third Rock’s $45M venture makes synthesizing na... | Nature’s been a fantastically bountiful source of medicine, sure. But turns out the drug compounds f... | medcitynew... |
- | AI researcher from Alphabet’s Calico Labs launches startup a... | A former Stanford University researcher who served as chief computing officer at Alphabet anti-aging... | medcitynew... |
- | Third Rock Ventures raises $426M, opens West Coast office | Boston investment firm Third Rock Ventures LLC has raised $426 million for its second (oversubscribe... | medcitynew... |
- | Third Rock hearing loss startup Decibel Therapeutics launche... | Third Rock Ventures is launching a startup geared at broadly treating hearing loss – leading a $52 m... | medcitynew... |
- | Epigenetics player Constellation Pharma raises $5 million; l... | Right on the heels of embarking on two new Phase 1 trials, epigenetics player Constellation Pharma h... | medcitynew... |
- | Two biotech startups tackle hearing loss | Microscopic image of hair cells and their progenitors.
Modern life is bad for hearing. Industry, tra... | medcitynew... |
- | Sanofi’s Viehbacher thinks Big Pharma will seek earlier-stag... | Sanofi (NYSE:SNY) CEO Chris Viehbacher has definite thoughts about how to marry life science ideas w... | medcitynew... |
- | New biotech startup for therapeutic cancer vaccines includes... | It’s the holy grail of cancer treatments: cancer therapeutics that use the immune system to destroy ... | medcitynew... |
- | GSK, JNJ form $200M fund with Index Ventures for early stage... | Who says early stage life science ventures don’t have access to funding?
GlaxoSmithKline (NYSE:GSK) ... | medcitynew... |
- | Protein-motion startup launches armed with $57M to develop d... | A picture may be worth a thousand words, but when it comes to disease discovery, Bay Area VC firm Th... | medcitynew... |
- | Venture firm launches rare blood disorder therapeutics devel... | Venture capital firm Third Rock Ventures has launched a drug development startup to treat genetic bl... | medcitynew... |
- | A less invasive approach to combating eye diseases focus of ... | A collaboration between two biotherapeutics companies could lead to less invasive approaches to trea... | medcitynew... |
- | FDA-approved cancer drug gets revised label, better results ... | The U.S. Food and Drug Administration has approved a revised label for cancer drug Gleevec following... | medcitynew... |
- | Fundraising: Gene therapy firm targeting sickle cell anemia ... | Company name: bluebird bio.
Industry: Biotechnology.
Location: Cambridge, Massachusetts.
Product: Ge... | medcitynew... |
- | No shying away from early-stage deals here. Third Rock Ventu... | While many healthcare venture capital firms continue to ease away from early-stage deals, Third Rock... | medcitynew... |